BDC.NYSEBelden INC

Form 4: Belden Inc. CEO Ashish Chand Reports Transaction in Company Stock

Sentiment:

SEC Form 4 Filing


Ashish Chand, President and CEO of Belden Inc., reports the exercise of stock appreciation rights and a related transaction involving company stock.

Delay expectedThe stock appreciation rights were initially cancelled due to incorrect settings in the administrator's systems, causing a delay in the exercise.

Summary

  • On March 6, 2024, Ashish Chand, the President and CEO of Belden Inc., executed a transaction involving Belden's common stock.
  • Chand exercised 537 stock appreciation rights (SARs) at a price of $72.57.
  • As a result of the SAR exercise, Chand acquired 537 shares and disposed of 44 shares to cover tax withholding obligations.
  • The fair market value of the stock on the exercise date was $87.14.
  • Following the reported transactions, Chand directly owns 82,978 shares of Belden Inc. common stock.
  • Chand also indirectly owns 977.3295 shares through a 401(k) plan.
  • The stock appreciation rights were to be automatically exercised on the expiration date if the fair market value exceeded the grant price, but due to incorrect settings in the administrator's systems, the awards were initially cancelled and then corrected.

Sentiment

Score: 6

Explanation: The document is a neutral regulatory filing detailing a stock transaction. The initial system error is a minor concern, but overall, the sentiment is relatively neutral.

Risks

  • System errors in the administrator's systems initially caused the cancellation of the stock appreciation rights exercise, which could indicate potential weaknesses in internal controls or administrative processes.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, like the CEO, who trade in their company's stock; it provides transparency to the market.

Stakeholder Impact

  • The transaction provides transparency to shareholders regarding insider activity.
  • The initial system error in the SAR exercise could raise concerns among shareholders about the company's internal controls.

Key Dates

DateDescription
June 26, 2019Date of the Limited Power of Attorney for Section 16 Reporting Obligations.
March 4, 2015Date of the grant agreement for the stock appreciation rights.
March 4, 2024Original expiration date of the stock appreciation rights.
March 6, 2024Date of the stock transaction (exercise of SARs).
March 8, 2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.